https://www.selleckchem.com/pr....oducts/jak-inhibitor
Earlier studies have suggested that the leukocyte redistribution can be considered as an immunological marker of the clinical response to corticosteroids (CS), representing an easy measurable potential biomarker in severe asthma. The aim of this study was to determinate the utility of the leukocyte redistribution as a biomarker of disease heterogeneity in patients with severe asthma and as a bioindicator of potential CS resistance. We developed an unbiased clustering approach based on the clinical data and the flow cytometry res
Mi piace
Commento
Condividi
